$1,116.11
-5.06 (-0.451%)
At Close: Aug 04, 2026
Will the Invesco Pharma ETF or iShares Global Healthcare Fund Be the Better Health Care Fund in 2026?
10:17am, Monday, 20'th Jul 2026
IXJ offers broader diversification with 110 holdings and a lower 0.40% expense ratio, while PJP's concentrated U.S. pharma strategy delivered a 44.90% one-year return.
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Monday, 20'th Jul 2026
Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Boston Common Asset Management LLC Cuts Stock Position in Eli Lilly and Company $LLY
08:18am, Monday, 20'th Jul 2026
Boston Common Asset Management LLC cut its stake in shares of Eli Lilly and Company (NYSE: LLY) by 10.6% in the first quarter, according to its most recent disclosure with the SEC. The firm owned 24,3
Broderick Brian C Has $8.52 Million Position in Eli Lilly and Company $LLY
07:44am, Monday, 20'th Jul 2026
Broderick Brian C increased its position in shares of Eli Lilly and Company (NYSE: LLY) by 12.8% in the first quarter, according to the company in its most recent disclosure with the SEC. The institut
Decker Wealth Management LLC Purchases New Shares in Eli Lilly and Company $LLY
07:08am, Monday, 20'th Jul 2026
Decker Wealth Management LLC acquired a new stake in Eli Lilly and Company (NYSE: LLY) during the first quarter, according to its most recent disclosure with the SEC. The institutional investor acquir
AlTi Global Inc. Buys 941 Shares of Eli Lilly and Company $LLY
04:09am, Monday, 20'th Jul 2026
AlTi Global Inc. boosted its stake in shares of Eli Lilly and Company (NYSE: LLY) by 29.8% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SE
3 Biggest Pharma Giants: Buy, Sell or Hold?
09:30am, Sunday, 19'th Jul 2026
The three biggest US pharma names by market cap trade at very different setups right now: Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) at $247.02 screens as the most compelling on fundamentals,
Our Top 10 High Growth Dividend Stocks - July 2026
08:15am, Sunday, 19'th Jul 2026
The article provides a methodology for selecting high-growth dividend-paying stocks, focusing on dividend growth and sustainability rather than high current yield. We use our proprietary models to rat
Dorsey Wright & Associates Makes New Investment in Eli Lilly and Company $LLY
04:27am, Sunday, 19'th Jul 2026
Dorsey Wright and Associates purchased a new stake in Eli Lilly and Company (NYSE: LLY) during the first quarter, according to its most recent 13F filing with the SEC. The firm purchased 508 shares of
AI Bubble Risks Make Dividend Stocks Attractive Again
01:03pm, Saturday, 18'th Jul 2026
I identify dividend stocks and REITs that could protect investors from AI bubble risks, geopolitics, and inflation while generating attractive income. My "ALLKA Dividend Rating" model separates qualit
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of A
Lulu's Fashion Lounge Holdings (NASDAQ:LVLU) retained Solomon Partners as its financial advisor and Willkie Farr & Gallagher LLP as its legal advisor as the company evaluates strategic alternatives to
Eli Lilly Stock Hovers In Buy Zone, Finds Key Support Amid $3 Billion Deal
01:04pm, Friday, 17'th Jul 2026
Sector leader Eli Lilly is in a buy zone above a pivot at 1,133.95 ahead of second-quarter results, due on Aug. 5.
Eli Lilly to Boost Neuroscience Pipeline With AtaiBeckley Buyout
12:36pm, Friday, 17'th Jul 2026
LLY agrees to acquire AtaiBeckley for $2.8B upfront to expand its neuroscience pipeline with psychedelic therapies for mental health disorders.
Looking to diversify away from AI trade? Buy these 3 stocks
08:58am, Friday, 17'th Jul 2026
For investors seeking to pare exposure to the artificial intelligence (AI) trade amid boom-induced volatility, shifting capital toward overlooked equities offers a compelling strategic alternative. Ma
Sign In
Buy LLY